EVOLUS INC

EOLS stock represents shares of Evolus, Inc., a medical aesthetics company listed on the Nasdaq under the ticker EOLS. The company develops and commercializes aesthetic products, including its flagship Jeuveau neurotoxin for frown lines. EOLS stock gives investors exposure to the fast-growing medical aesthetics market, competing with established players like Botox. Its performance is tied to product adoption, regulatory approvals, and expansion into new markets.

Recent performance for EOLS depends on market sentiment, quarterly results, and news specific to Evolus. For the most up-to-date price changes and trends, check the live EOLS quote and performance chart on this page. The stock has historically shown volatility due to its growth-stage profile and competition in the aesthetics space. Reviewing recent trading volume and price action can help contextualize current momentum.

The 52-week range shows the lowest and highest prices at which EOLS traded over the past year, providing perspective on volatility and price extremes. This range is updated regularly and can be found in the key statistics section on this page. It helps investors gauge where the current price sits relative to its annual high and low, but it does not predict future movement.

Evaluating EOLS valuation involves examining metrics such as price-to-sales, price-to-book, and enterprise value-to-revenue, since the company may not have consistent positive earnings. Comparing these multiples to peers in the medical aesthetics and biotech sectors provides context. Additionally, assessing pipeline potential, revenue growth trajectory, and cash burn rate is important. The current valuation metrics are displayed on this page for reference.

EOLS can be traded in pre-market and after-hours sessions through many brokers, though liquidity is typically lower and spreads wider than during regular trading hours. Extended-hours trading carries additional risks, including price volatility and limited order types. Not all brokers offer this feature, so check with yours. Regular market hours for Nasdaq are 9:30 a.m. to 4:00 p.m. ET on trading days.

Key risks for EOLS include intense competition from larger aesthetics companies, dependence on a limited product portfolio, regulatory hurdles, and potential reimbursement or pricing pressures. As a smaller, growth-oriented company, it may face cash burn and needs to achieve profitability. Market sentiment and broader economic conditions can also affect the stock. Investors should review the company's SEC filings for detailed risk factors.